Truist raised the firm’s price target on Affirm to $28 from $24 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 earnings in FinTech. Many of the firm’s covered names are slumping, and while broadly constructive, Q3 results may not be catalysts for some of its “favorite laggard ideas”, the analyst tells investors in a research note. Truist also believes that the challenges, including competition, commoditization, price pressure, and investments needed to move up-market and into more complex SMBs will not quickly abate. The firm adds however that the “Buy-Now-Pay-Later” option is a viable and durable credit and debit card substitute that is here to stay, even though rising long-term interest rates have stalled Affirm’s recent run.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AFRM:
- Affirm Holdings put volume heavy and directionally bearish
- Unusually active option classes on open September 29th
- Affirm participates in a conference call hosted by Deutsche Bank
- Weave partners with Affirm to expand payment options for patients
- Affirm Holdings (NASDAQ:AFRM) Craters as It Considers Subscription Service
